Does Nektar Therapeutics (NASDAQ:NKTR) Look Expensive At $1.65? Here’s How To Know.
In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.71 million shares changing hands with its beta currently measuring 0.71. Company’s recent per share price level